Current Research with transfer factors

Current Research with transfer factors

Today in the final decade of this century studies involving transfer factors are consistently showing up worldwide. Several including those from the National Academy of Science of the United States of America (15) have focused on the transmission relationship between an HIV type I infected mother and her unborn child. Generally when the mother's viral load is decreased so is the likelihood of HIV-I being transmitted to the baby. This was observed in 1995 from a group of thirty HIV I pregnant women.

Eight of the ten women with the highest levels of HIV-I RNA (above 50 000 copies per milliliter) transmitted the disease at delivery while none of the twenty women with lower levels (below 20 000 HIV-I RNA copies per milliliter) passed HIV-I on to their children.

Dr. H. Hugh Fudenberg M.D. has greatly broadened research and treatment efforts using transfer factors. To date he is the only one to have successfully treated subsets of Alzheimer's Disease Autism Chronic Fatigue Syndrome and subsets of ALS (Louhig’s Disease). Similar work by others points to Myasthenia Gravis and Multiple Sclerosis as having an immunological base which can be altered or reversed through large amounts of transfer factors(6 16 17).

Infected patients who are tracked up to ten years show positive residual effects from transfer factors.(6). A large number of peer-reviewed scientific papers testified to these facts as well as transfer factors consistent track record of partially or completely reversing specific viral infections. Immunological researchers continue to explore new treatment applications for transfer factors(6).